Evidence map›Paper›PMID 42368470›Full record

ArticlePolymer science & technology (Washington, D.C.)2026

pH-Ultrasensitive Polyester Nanoprobe for High-Contrast Tumor Imaging with Superior Biocompatibility.

Yuxuan Zeng, Jihong Wang, Hongbin Zhu, Dun Luo, Huosheng Zhou, Chanjuan Su, Yan Bao, Xianzhu Yang, Jun Wang, Dong Luo and 1 more

Abstract read
In one paragraph

Article in Polymer science & technology (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuxuan ZengSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.
Jihong WangSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.
Hongbin ZhuSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.
Dun LuoSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.
Huosheng ZhouGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China.
Chanjuan SuGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China.
Yan BaoGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, P. R. China.ORCID https://orcid.org/0000-0002-5072-9428
Xianzhu YangSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.ORCID https://orcid.org/0000-0002-1006-0950
Jun WangSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.
Dong LuoSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.ORCID https://orcid.org/0000-0002-9711-2070
Menghua XiongSchool of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, P. R. China.ORCID https://orcid.org/0000-0003-0020-5965

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transistor-like nanoprobes enable highly sensitive detection of dysregulated pH, showing great promise for tumor imaging. Their pH sensitivity arises from protonation of ionizable tertiary amines on the polymer side chains, which can increase the interaction with negatively charged cell membranes, raising risks of cytotoxicity and biosafety. Herein, we present a platform of pH-ultrasensitive polyester nanoprobes (pUPNs) that exhibit minimal toxicity upon activation and feature tunable pH responsiveness. The pUPNs self-assemble from pH-responsive polyesters, whose backbones possess high steric hindrance to minimize interactions with cell membranes. Their side chains are covalently grafted with ionizable tertiary amines and self-quenched fluorescent dyes to finely adjust the sensitivity to subtle pH variations. Interestingly, pUPN with the lowest transition pH exhibits the best tumor imaging contrast. These pUPNs demonstrated excellent biocompatibility after intravenous administration with no detectable hepatic or renal toxicity. This study presents a design platform for pH-ultrasensitive nanoprobes with excellent sensitivity and biocompatibility through increased steric hindrance in the polymer backbone.

Indexed as

biosafetyhigh steric hindrancenanoprobespH-ultrasensitivepolyester

Identifiers

PMID42368470
PMCPMC13295190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.